News from spero therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 30, 2017, 08:30 ET Spero Therapeutics Presents New Data on Lead Potentiator Candidate SPR741 at ASM Microbe 2017

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop multiple novel therapies for the treatment of bacterial infections, today...


May 22, 2017, 08:30 ET Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


May 04, 2017, 08:30 ET Spero Therapeutics Receives Grant from National Institutes of Health to Explore Novel Treatment Combinations for Tuberculosis

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


Apr 18, 2017, 08:30 ET Spero Therapeutics Highlights Potentiator Program Data at the 27th European Congress of Clinical Microbiology and Infectious Diseases

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, will present...


Mar 30, 2017, 11:05 ET Spero Therapeutics Receives $6.8 Million Award from CARB-X to Combat Antibiotic-Resistant Bacteria

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, announced today that it ...


Mar 28, 2017, 08:30 ET Spero Therapeutics to Present at 16th Annual Needham Healthcare Conference

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced today that Ankit...


Mar 08, 2017, 07:30 ET Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced today that it has...


Feb 28, 2017, 07:30 ET Spero Therapeutics to Present at Upcoming March Conferences

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


Jan 31, 2017, 07:30 ET Spero Therapeutics Acquires Next Generation Antibacterial Candidates from Pro Bono Bio for Treatment of Multidrug-Resistant, Gram-Negative Infections

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced it ...


Nov 10, 2016, 04:01 ET Spero Therapeutics to Present at Two Upcoming November Conferences

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


Oct 18, 2016, 09:00 ET Spero Therapeutics Announces $1.65 Million Award from Department of Defense to Develop Novel Combination Therapy for Multidrug-Resistant, Gram-Negative Pathogens

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


Sep 06, 2016, 09:00 ET Spero Therapeutics to Participate in Citi's 11th Annual Biotech Conference

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, announced today...


Sep 06, 2016, 08:00 ET Spero Therapeutics Joins ENABLE (European Gram-Negative Antibacterial Engine) Project to Combat Antibiotic-Resistant Bacteria

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, announced they are ...


Aug 15, 2016, 04:01 ET Spero Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced today that Ankit...


Jun 20, 2016, 12:30 ET Spero Therapeutics Unveils Data on Lead Potentiator Candidate for the Treatment of Multidrug Resistant Gram-Negative Infections at ASM Microbe 2016

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today revealed...


Jun 08, 2016, 09:00 ET Spero Therapeutics to Unveil Data on Potentiator Platform at ASM Microbe 2016

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


May 25, 2016, 08:00 ET Spero Therapeutics Acquires Novel Gyrase Inhibitors from Vertex Pharmaceuticals

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced...


Apr 05, 2016, 09:00 ET Spero Therapeutics to Present at the 15th Annual Needham Healthcare Conference

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced today that Ankit...


Mar 02, 2016, 09:30 ET Spero Therapeutics Hires Cristina Larkin as Chief Commercial Officer

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced the...


Feb 29, 2016, 09:30 ET Spero Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced today that Ankit...


Feb 02, 2016, 09:30 ET Spero Therapeutics Announces $30 Million Series B Preferred Financing

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced existing Series A...


Jan 19, 2016, 09:30 ET Spero Therapeutics Hires Former Biomedical Advanced Research and Development Authority (BARDA) Anti-Infectives Program Chief

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, announced the...


Jan 07, 2016, 09:00 ET Spero Therapeutics Licenses Dihydrofolate Reductase Inhibitors from Promiliad Biopharma to Enhance Anti-Infective Pipeline

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced it ...